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Surgical treatment of peri-implantitis and it's effects on
Matrix metallopeptidase 8 (MMP-8) levels
Objective: A case-control study was performed to examine possible differences in MMP-8 
levels before and after surgical treatment of peri-implant osseous defects with porous 
titanium granules. Method: Subjects with osseous defects around dental implants (n = 36) 
were treated with two different methods of peri-implantar therapy. One control group 
(N=17) were treated with conventional peri-implantar operation (open flap debridement), 
whilst the case group (N=19) was treated with porous titanium granules in addition to open 
flap debridement. Samples of peri-implantar sulcus fluid were collected before treatment 
and at one-year follow-up. The level of MMP-8 were tested in each samples using ELISA. 
The results are presented as the ratio between MMP-8 and total protein in each individual 
sample. Results: There was a significant reduction in MMP-8 levels after one year 
compared to before surgery (N = 35), however the observed 25% reduction within each 
group (case and control) failed to be significant. There was no difference in the MMP-8 
levels between the control and case group after one year. Conclusions: There is a 
reduction in MMP-8 levels in peri-implantar sulcus fluid after surgical treatment; however 
there was no difference between the two treatment strategies.
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1 Introduction/ background
Peri-implantitis is an inflammation round the supporting tissue of dental implants, with 
resulting destruction of this surrounding tissue and eventually loosening of the implant. A 
correlation between peri-implantitis and other diseases as endocarditis has also been 
described1.
Between three and five percent of dental implants are lost during the first five years after 
installation. The main risk factors for implant loss are smoking, short implant length2 and 
history of periodontitis3.
The inflammation may aetiologically be considered as a mixed bacterial infection, where 
the subsequent inflammation through time destroys the surrounding tissue4. This is due to 
the hosts response to microbial endo- and/ or exotoxins. This loss has several 
inflammatory causes, including
• Destruction of bone through Receptor Activator for Nuclear Factor κ B Ligand 
(RANK-L)- activated osteoclasts (several inflammatory mediators acts as RANK- 
ligand)
• Destruction of collagen by MMP-8/neutrophil collagenase from polymorphonuclear 
leukocytes (PMN) 
• Destruction of collagen through bacterial enzymes.
It has been done more research on periodontitis than peri-implantitis regarding terms of 
bone degradation and biofilms, but there are great similarities between the two diseases. 
For example, studies of biofilms around dental implants and teeth have not shown any 
significant differences between their structure and composition, neither in cross-sectional 
nor longitudinal studies5.
1.1 Concepts
The following terms are widely used in the paper, and are 
reviewed in the following sections
Dental implant: Artificial and tissue friendly substititute for 
a tooth. It consists of a fixture (usually made of titanium) 
screwed into jaw bone. The bone modulates around it, so 
that the fixture is osseointegrated. After a few months 
without load, an abutment (short extendor pipe) is 
integrated with this system, after which fixed 
prosthodontics (crowns, bridges et cetera) can be 
attached on top (figure 1)6.
1 Loesche WJ, Journal of Dental Research 1996; 75; 1432   
(http://jdr.sagepub.com/cgi/reprint/75/7/1432.pdf) (last visited 13.5.2010)
2   Baelum, V. and Ellegaard, B, The Journal of Periodontology 2004; 75 (10); 1404-1412
3    Roos-Jansåker A-M. et al, The Journal of Clinical Periodontology 2006; 33; 283-289
4 Lindhe, J.  (2003) Clinical Periodontology and Implant Dentistry (4.th edition). Oxford: Blackwell 
Publishing Ltd page 163
5 Lindhe, J.  (2003) Clinical Periodontology and Implant Dentistry (4.th edition). Oxford: Blackwell 
Publishing Ltd page 98
6 Øyri, A. (2003) Norsk medisinsk ordbok (7.th edition). Oslo: Det Norske Samlaget. Entry: «Implantat»
Figure 1: Comparison between 
dental implant and natural tooth 
(basis from 
http://chandigarhdentist.com/imp
lants/images/PartsOfImplant.gif)
Endotoxins: Toxins inside the bacterial bodies7.
Exotoxines: Toxins on the bacterial surface8.
Receptor Activator for Nuclear Factor  κ   B Ligand (RANK-L)  also known as TNF-related 
activation-induced cytokine (TRANCE), osteoprotegerin ligand (OPGL), and ODF 
(osteoclast differentiation factor), is a molecule important in bone metabolism. This natural 
and necessary surface-bound molecule found on osteoblasts serves to activate 
osteoclasts, which are the cells involved in bone resorption (Yasuda, H. et al 1998 March 
31; 95(7): 3597–3602)9.
Osteoclast: Multi-nucleated giant cells which contributes to bone degradation by proteolytic 
digestion (hydrolysis of peptide bonds)10.
Biofilm: Coating/ plaque on surface, consisting of bacteria, their products and particles/ 
matter from the host/ the surroundings11.
PMN (PolyMorphoNuclear leukocytes): A subgroup of leukocyes (white blood cells), filled 
with granules of toxic chemicals that enable them to digest micro-organisms by 
phagocytosis.  These cells are important contributor to the innate immediate immune 
system. Move towards the site of inflammation by means of chemotaxis (movement agains 
a chemical gradient).12.
 
Inflammation: Tissue response to infection and trauma characterized by the four cardinal 
signs dolor (pain), calor (heat), rubor (readness) and tumor (swelling). In addition, 
sometimes functio laesa (loss of function) is added. The clinical symptoms are due to 
increased blood perfution and vasopermeability, and increased leakage from the capillary 
walls because of greater extravasal concentration of proteins and leucocytes (white blood 
cells)13.
PISF (Peri-Implantar Sulcus Fluid): GCF (Gingival Crevicular Fluid)- analogue around 
implants, id est various plasma proteins, tissue proteases, inhibitors and breakdown 
products and leukocyte enzymes14.
7 Øyri, A. (2003) Norsk medisinsk ordbok (7.th edition). Oslo: Det Norske Samlaget. Entry: «Endotoksin»
8 Øyri, A. (2003) Norsk medisinsk ordbok (7.th edition). Oslo: Det Norske Samlaget. Entry: «Eksotoksin»
9 Yasuda, H. et al, Proceedings of the National Academy of Sciences of U S A. 1998 March 31; 95(7): 
3597–3602 (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC19881/)
10 Øyri, A. (2003) Norsk medisinsk ordbok (7.th edition). Oslo: Det Norske Samlaget. Entry: «Osteoclast»
11 Øyri, A. (2003) Norsk medisinsk ordbok (7.th edition). Oslo: Det Norske Samlaget. Entry: «Biofilm»
12 http://www.hon.ch/Library/Theme/Allergy/Glossary/wbc.html  , Last visited 18.5.2010
13 Øyri, A. (2003) Norsk medisinsk ordbok (7.th edition). Oslo: Det Norske Samlaget. Entry: «Betennelse»
14 Lindhe, J.  (2003) Clinical Periodontology and Implant Dentistry (4.th edition). Oxford: Blackwell 
Publishing Ltd page 58
1.2 Anatomy of the peri-implantium
The peri-implantium consists of the gingiva and the alveolar bone proper. Histologically 
these tissues are made up of the following main cells and structures:
Gingiva (its lamina propria): Usually it consists of approximately 40 percent epithelium and 
60 percent connective tissue. The connective tissue have the following components: 60 
percent collagen (type I, II and III), 13 percent fibroblasts, seven percent vessels and 20 
percent other tissues (intercellular matrix and nerves et cetera)15
Alveolar bone proper (id est the part of bone surrounding the implant, that is the bone-
implant interface): A mineralized structure consisting of inorganic and organic matter. The 
organic part is composed of collagen type I and ground substance (different types of 
proteins)16.
1.3 MMPs
Matrix MetalloProteinases (MMPs) makes up a group of zinc and calcium dependent 
endopeptidases which degrades different types of ExtraCellular Matrix (ECM) depending 
on type of MMP. They have different physiological tasks, which range from natural tissue 
remodeling to pathological conditions like cancer.
The proteolytic activity of MMPs are regulated by activation of proenzyms and inhibition of 
active enzymes by endogen inhibitors, α2- macroglobulin and Tissue Inhibitors of 
MetalloProteinases (TIMPs)17.
MMP-8 (Matrix MetalloProteinase- 8) is a zink dependent collagen splitting MMP which is 
found in connective tissue all over the body, and is secreted as inactive proenzymes. 
There are higher concentrations of MMP-8 in saliva than exempli gratia wound fluid, and 
precautions have to be made not to contaminate PISF- samples with this18.
The enzymes get activated by autolysis (by the enzyme itself) or other factors as oxygen 
radicals and proteinases in secondary granules of neutrophils.
MMP-8 splits collagen I, II and III19. 
1.4 Enzymatic diagnostics
Enzyme diagnostics is a relatively recent field in medicine, and measures intra cellular 
enzymes released to tissue fluid and plasma during tissue damage. This is done to tell 
something about
• which organ/ organ system that is affected
• the extent of the disease and/ or 
• monitor progression/ development of a disease20
15 Lindhe, J.  (2003) Clinical Periodontology and Implant Dentistry (4.th edition). Oxford: Blackwell 
Publishing Ltd page 19
16 Janqueira, L. C. (1998) Basic Histology (9.th edition). Rio deJaneiro: Editoria Guanaharu Koogan S. A. 
page 137
17 http://www.rndsystems.com/pdf/dmp800.pdf   page 3 (last visited 13.5.2010)
18 http://www.rndsystems.com/pdf/dmp800.pdf   page 13 (last visited 13.5.2010)
19 http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=4317   (last 
visited 13.5.2010)
20 Stokke, O. (2006). Klinisk biokjemi og fysiologi (3.rd edition). Oslo: Gyldendal Norsk Forlag AS page 37-
38
The idea is that deviations from normal enzyme patterns can give a hint about the reason 
for the deviation, how serious the deviation is and/ or give the disease a quantifiable 
parameter (in the shape of one or more enzymes) to follow its progression.
The MMP-8 system consists, as mentioned, of a constitutive expressed extra cellular 
proenzym that lyses by different influences, and not intra cellular enzymes that are 
released during tissue damage. It is therefore not enzyme diagnostics in narrow sense of 
the term. It is still appropriate to use this terminology, because one uses enzyme changes 
to assess extent and progression of disease  
1.5 ELISA
ELISA (Enzyme-Linked Immuno Sorbent Assay) is 
a bichemical survey method which is used for 
quantitative measurements of proteins and other 
molecules that can stick to an enzyme. ELISA is 
considered a good method amongst other 
biochemical laboratory techniques in terms of 
sensitivity and specificity21.
The technique involves microtiter wells that are 
covered by monoclonal antibodies that are specific  
for the substance that are to be analyzed. When 
the samples are added to these wells, the 
substance of interest will stick to the antibodies; thereafter another monoclonal antibody is 
added. This binds to another epitope (molecular site), and is connected with yet another 
molecule (with specific light absorbing qualities) for later measurement of absorbance.
The sensitivity is thus partly dependent on the antibodies' affinity to the epitopes.
The colour change that occurs is proportional to the amount of bound protein, and the 
concentration of this is determined by comparison with standard curve of known 
concentrations of cytokines.
21 http://www.mabtech.com/main/Page.asp?PageId=26&PageName=About+ELISA   (last visited 13.5.2010)
Figure 2 Microtiter plate (from 
http://www.biology.arizona.edu/immuno
logy/activities/elisa/elisa_intro.html)
1.6 Surgical treatment and porous titanium granules
Conventional surgical procedure for treatment of peri-implanitis is to 
elevate a flap at the implant site, and clean the surface («open flap 
debridement») by means of hand instruments and H2O2.
In the later years several additional methods and techniques have 
been developed to treat and heal osseous defect. Amongst these are
• regenerating enzymes (emdogain and others)
• bone grafts from other species (bio-oss and others)
• allotransplantation (bone grafts from the same patient)
• different materials to support osteoconduction (porous titanium 
granules and others)
Porous titanium granules are swamp-like «rocks» that are 
thrombogenic and able to make blood clot. When mixed with exempli 
gratia blood, the granulae stick to each other. The granulae-clot- complex promotes 
osteoblast colonization and creates a pattern for new bone growth22.
22 http://www.biodent-systems.com/TigranBrochure.pdf   (last visited 13.5.2010)
Figure 3. Osseous 
defect filled with  
porous titanium 
granules (with 
permission from 
Johan Caspar 
Wohlfahrt)
2 Materials and methods
PISF samples were taken from 36 patients distributed in two groups (19 case patients and 
17 controls) before surgical treatment and on one year follow-up. This was performed by 
dipping standard endodontic paper points size 50 in the peri-implantar sulcus for ten 
seconds in every (buccal, mesial, distal and palatal/ lingual) aspect of the implant. The 
implant area was air dried and isolated with cotton rolls prior to sampling.
Each sample was collected by the same operator, to achieve approximately similar 
sampling parameters, and minimize inter-operator bias. 
The samples were coded, immediately frozen after collection, and stored at minus 80 
degrees celcius. The analyses were performed by another operator. 
During analysis an operator error to one of the samples, which was later revealed as a 
control sample, reduced the number of samples in the control group to 16, resulting in 35 
paired samples (pre-surgery and one year follow-up), a total of 70 samples.
All tests were performed at Oral research laboratory at the Faculty of Dentistry in Oslo
2.1 MMP-8
«Quantikine® Human Total MMP-8 Immunoassay» (DMP800) from R & D Systems was 
used.
Standards in the range from 0 to 10 ng/ ml was prepared and pipetted to two duplicate 
wells23. 
The PISF samples were slowly thawed and centrifuged for one minute, after which it was 
possible to extract 10µl sample fluid. These were diluted 1/20 with RD5-10 (190 μl RD5-10 
to 10 μl sample), of which 50 μl was delivered into marked ELISA wells on same plate as 
the standard solution. The rest was preserved for measurements of total protein (see later) 
and future reference.
To each sample-RD5-10- solutions (50 μl) was pipetted 150 μl RD 1-52. The plate was 
then incubated for two hours with gentle shaking, whereafter the wells were emptied and 
washed four times with wash buffer. Now 200 μl MMP-8- conjugate was added each well, 
and incubation pluss gentle shaking in additional two hours. Then 200 μl substrate solution 
was added, and yet another incubation (30 minutes) was initiated. Finally 50 μl stop 
solution was added to each24.
The microtiter plate was then immediately analyzed using a Cobas
Mira chemistry analyzer (Roche Diagnostics, Germany) and absorbance read at 450 nm. 
The absorbance is given in table 1. A regression line based on the absorbance of the 
standard solution (figure 5), and the concentrations of MMP-8 was calculated from this 
using the values of the different wells. It was compensated for dilution (table 1).
23 http://www.rndsystems.com/pdf/dmp800.pdf   page 7 (last visited 13.5.2010)
24 http://www.rndsystems.com/pdf/dmp800.pdf   page 8 (last visited 13.5.2010)
 
 
2.2 Total proteins
«Pierce BCA Protein Assay Kit» (23225) from Thermo Scientific was used to quantify the 
amount of proteins in each sample.
Standards in the range from 0 to 2000 μg/ ml was prepared and pipetted to two duplicate 
wells25.
25 μl from each of the previously prepared wells was pipetted onto a new microtiter plate
Substrate solution was prepared by mixing the BCA reagent B and BCA reagent A in a 
1/50- relation (380 μl BCA-B to 18620 μl BCA-A). 200 μl of this mixture was added to each 
well and mixed 5 times by pipetting.
The solution was incubated under gentle shaking and measured for absorbance.
The measured values were beyond the standard, and it was decided to dilute the samples 
another ten times using BCA-A and-B, to a total dilution of 1 / 80.
The new values were within the standard (Table 2). Another regression line was computed 
(Figure 6), and the amount of total protein was calculated based on this. It was 
compensated for the dilution (Table 3)26.
25 http://www.piercenet.com/files/1296as8.pdf   page 2 (last visited 13.5.2010)
26 http://www.piercenet.com/files/1296as8.pdf   page 2-3 (last visited 13.5.2010)
Table 1. The absorbance values for MMP-8 in each individual samples  As we see, several  
of the values are above the values of the standard curve [0,73, 0,01]. These values are  
therefore extrapolated according to the graph.
Figure 4. The regression line and 
calculation formula for MMP-8, 
based on the absorbance of the 
standard solutions.
2.3 Statistics
All calculations were performed using Sigma plot (Sigma Diagnostics St.Louis, USA). 
The ratio between MMP-8 and total protein content was calculated for each sample and 
the difference before and after treatment was performed using a paired t-test, whereas the 
difference between the groups were tested using non-parametrical test (Mann-Whitney 
Rank Sum Test). If normality test passed, Student t- test was performed. A P-value < 0.05 
was considered significant.
Table 2: Absorbance (total protein)
Figure 5: Regression line for absorbance of standard solution (total protein)
3 Results
The case and control groups were comparable with respect to age, sex, diabetes, stress 
level and other relevant factors for peri-implantitis level. The analysis was done blindly by 
one operator collecting the samples, whilst the analysis was done by an operator who did 
not know who the samples came from. 
There was a significant reduction (P =0.043) in MMP-8/ total protein levels between before 
(pre) and after surgery (post) for the whole study population (n= 35) (figure 6). 
Figure 6. The MMP-8/ total protein 
levels before (pre) and one year 
after (post) surgery. 
There was no difference between the samples collected before or after the two surgical 
methods (case and control) (figure 7). It seemed to be a difference in the median value for 
the two groups prior to surgery, but this was not significant.
Figure 7: The MMP-8/ total protein 
levels before (pre) and after (post)  
the two different surgical procedures 
(case and control).
There was not a difference in the change in MMP-8/ total protein levels (pre-post) between 
the two groups (case and control) (Fig. 8).
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Figure 8: The change in 
MMP-8/ total protein ratios 
presented in % of level prior  
to surgery
4 Discussion
We observed a significant reduction in the relative MMP-8 level in samples collected a 
year after a surgical procedure compared to before in peri-implantitis patients; however we 
found no difference in MMP-8 levels between the two different surgical methods; 
conventional surgical procedure (control) and the use of titanium granules (case).   
MMPs are catalytic proteins, enzymes capable of cleaving almost all extracellular matrix 
(ECM) and basement membrane (BM) proteins. MMPs are involved in many physiological 
processes such as bone formation, tooth eruption, and wound healing. On the other hand, 
MMP expression and activation is disturbed in many pathological conditions such as 
cancer27, oral cysts 28, and periodontitis29. An enhancement in MMP-8 due to severity of 
peri-implantitis or oral pathological conditions has been reported; however this is to the 
authors’ knowledge the first observation in reduced MMP-8 levels one year after surgery.
Our results demonstrate that there are changes in PISF composition before and after 
surgery, and that it may be possible to find markers for the degree of peri-implantar 
decomposition, early detection of such based on this and/ or monitor treatment outcome. 
MMP-8 may be such a marker, but this study doesn't say anything about this, since the 
results were not evaluated with respect to therapeutically outcome.
As suggested by Kuula30 and Teronen, O. et al31, further investigations are needed to 
determine whether there is a corresponding reduction in MMP-8 levels in terms of 
periodontal surgery in relation to peri-implantitis surgery.
The cause of MMP-8's candidacy for such a diagnostic role is due to enhanced levels of 
MMP-8 in peri-implantitis sites. This is associated with extravasations and migration of 
PMN to sulcus / pocket of inflammation, and that the amount of this is related to the 
number of activated PMN, id est. the degree of inflammation. A pilot study by Xu et al. from 
2008, suggests that PISF have higher MMP-8 levels and activity than GCF from similar 
deep pockets32. None of these studies have, however, examined MMP-8 changes over 
time.
27 Sabeh, F et al, The Journal of Cell Biology 2004; 167 (4); 769-781   
(http://jcb.rupress.org/content/167/4/769.abstract) (last visited 18.5.2010)
28 Verstappen, J. and Von den Hoff, JW, Journal of Dental Research 2006; 85 (12); 1074-1084  
(http://jdr.sagepub.com/cgi/content/abstract/85/12/1074) (last visited 18.5.2010)
29 Wahlgren, J. et al, The Journal of Pathology 2001; 194 (2); 217-224 
(http://www.ingentaconnect.com/content/jws/path/2001/00000194/00000002/art00854) (last visited 
18.5.2010)
30 Kuula 2009 (https://oa.doria.fi/bitstream/handle/10024/45113/periodon.pdf?sequence=1) (last visited 
18.5.2010)
31 Teronen, O. et al, Journal of Dental Research 1997; 76 (9); 1529-1537 
http://jdr.sagepub.com/cgi/content/abstract/76/9/1529 (last visited 18.5.2010)
32 Xu, L. et al, Acta Odontologica Scandinavia 2008; 66 (4); 219-224 
(http://www.informaworld.com/smpp/content~content=a794876592&db=all) (last visited 18.5.2010)
We found no differences between the two surgical strategies, although a mechanism for 
an eventually greater reduction in MMP-levels in the case-group might be due to lower 
levels of PMNs at the implant site because of the titanium granules' anti-inflammatory 
function33. Such an effect might take place because of the formation of titanium dioxide 
(TiO2), which is formed spontaneously on exposed titan. Titanium dioxide has the ability to 
scavenge Reactive Oxygen Species (ROSs)34, which are one of the main activators of 
MMP-8, and result in less amounts of MMP-8 with the use of titanium granules (or other 
materials able to make a TiO2- layer) in the treatment of osseous defects. The reason why 
we did not find any such reduction, may be due to that the TiO2 effect initially was similar 
for both groups (implants of titanium), and that the use of titanium granules may only 
provide a negligible additional effect beyond this.
The level of MMP-8 in saliva is higher than the level in blood. Contamination of saliva in 
our samples might be one of the reasons for some of the high values and the great 
variation between individual samples in table 1, and one reason for lack of significant 
differences between the two surgical treatments as the statistical power ended up to be 
lower than desired. We chose to use all the samples, despite that several of them were 
outside the values of the standard curve, and some very much above (table 1). This was 
chosen in order not to reduce the sample size further, although statistical power is very 
adversely affected by small effect size.
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